Interestingly, endogenous TRAIL-R2 has recently been shown to promote proliferation of pancreatic cancer cells, in a ligand-independent manner, via inhibiting the processing of let-7 miRNA [177]. This evidence concerns the gene TNFRSF10B and pancreatic neoplasm.